组别

安罗替尼同步放化疗

常规同步放化疗方案

c2

P值

性别

14

(66.67%)

13

(61.90%)

1

0.872

7

(33.33%)

8

(38.10%)

中位年龄

62

65

>50

5

(23.81%)

7

(33.33%)

1

0.881

<50

16

(76.19%)

14

(66.67%)

病变部位

颈段

3

(14.29%)

3

(14.29%)

1

0.765

胸上段

5

(23.81%)

6

(28.57%)

胸中段

9

(42.86%)

7

(33.33%)

胸下段

4

(19.05%)

5

(23.81%)

病变长度(cm)

5.7 ± 1.3

5.4 ± 1.5

——

0.821

分化程度

4

(19.05%)

6

(28.57%)

1

0.698

10

(47.62%)

9

(42.86%)

7

(33.33%)

6

(28.57%)

TNM分期

II期

9

(42.86%)

10

(47.62%)

1

0.631

III期(除T4)

12

(57.14%)

11

(52.38%)

ECOG评分

0

6

(28.57%)

7

(33.33%)

1

0.664

1

11

(52.38%)

10

(47.62%)

2

4

(19.05%)

4

(19.05%)